Martha Chekenya

3.0k citations

41 papers · 2.1k indexed · h-index 25

Oncology top 5%
Molecular Biology top 10%
Immunology top 5%
Genetics top 2%
Cancer Research top 5%

Co-authors: Camilla Krakstad Per Øyvind Enger Jacques Zimmer Justyna Kmiecik Andrea Gras Navarro Aurélie Poli Per Øystein Sakariassen Heike Immervoll
Topics: Glioma Diagnosis and Treatment (19 papers)Immune Cell Function and Interaction (12 papers)T-cell and B-cell Immunology (7 papers)
Cited by: Genetics Immunology Oncology
Journals: Journal of Clinical Oncology The Journal of Immunology PLoS ONE
Partner nations: Norway Luxembourg United States

In The Last Decade

Martha Chekenya

41 papers receiving 2.0k citations

Peers

Countries citing papers authored by Martha Chekenya

Since Specialization

Citations

This map shows the geographic impact of Martha Chekenya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Chekenya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Chekenya more than expected).

Fields of papers citing papers by Martha Chekenya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Chekenya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Chekenya. The network helps show where Martha Chekenya may publish in the future.

Co-authorship network of co-authors of Martha Chekenya

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Chekenya. A scholar is included among the top collaborators of Martha Chekenya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Chekenya. Martha Chekenya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI 2023 ·Neuro-Oncology Advances ·(unknown),Dorota Goplen,Saruar Alam,Judit Haász,Leif Oltedal,Mohummad Aminur Rahman,Cecilie Brekke Rygh,Stein Atle Lie,Arvid Lundervold,Martha Chekenya	1
2	BORTEM-17: A phase IB/II single arm, multicentre study investigating the efficacy of sequential bortezomib and temozolomide in recurrent GBM with unmethylated MGMT promoter—The results of an interim analysis. 2023 ·Journal of Clinical Oncology ·Dorota Goplen,Mohummad Aminur Rahman,Petter Brandal,Tora S. Solheim,(unknown),(unknown),Leif Oltedal,Anne Simonsen,(unknown),(unknown),Judit Haász,Hrvoje Miletić,Stein Atle Lie,Martha Chekenya	1
3	P14.65 Survival in a consecutive series of 467 glioblastoma patients: impact of prognostic factors and recurrent treatment at two independent institutions 2021 ·Neuro-Oncology ·(unknown),(unknown),Mohummad Aminur Rahman,(unknown),Petter Brandal,(unknown),Martha Chekenya,Dorota Goplen	1
4	Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions 2018 ·Frontiers in Immunology ·(unknown),Mohummad Aminur Rahman,Justin V. Joseph,Andrea Gras Navarro,Martha Chekenya	40
5	Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients 2016 ·Cancer Research ·Mev Dominguez–Valentin,Andrea Gras Navarro,Mohummad Aminur Rahman,Surendra Kumar,(unknown),Elling Ulvestad,Vessela N. Kristensen,Morten Lund‐Johansen,Benedicte A. Lie,Per Øyvind Enger,Gro Njølstad,E. K. Kristoffersen,Stein Atle Lie,Martha Chekenya	26
6	Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors 2015 ·Frontiers in Immunology ·Andrea Gras Navarro,Andreas T. Björklund,Martha Chekenya	131
7	Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma 2014 ·OncoImmunology ·Justyna Kmiecik,Andrea Gras Navarro,Aurélie Poli,Jesús Planagumà,Jacques Zimmer,Martha Chekenya	24
8	Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma 2014 ·PLoS ONE ·Cecilie Brekke Rygh,Jian Wang,Marte Thuen,Andrea Gras Navarro,Else Marie Huuse,Frits Thorsen,Aurélie Poli,Jacques Zimmer,Olav Haraldseth,Stein Atle Lie,Per Øyvind Enger,Martha Chekenya	24
9	Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level 2013 ·Journal of Neuroimmunology ·Justyna Kmiecik,Aurélie Poli,Nicolaas H. C. Brons,Andreas Waha,Geir Egil Eide,Per Øyvind Enger,Jacques Zimmer,Martha Chekenya	310
10	Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours 2013 ·Journal of Neuro-Oncology ·Justyna Kmiecik,Jacques Zimmer,Martha Chekenya	52
11	Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation 2012 ·BMC Cancer ·Ingrid Moen,(unknown),Jian Wang,Karl-Henning Kalland,Martha Chekenya,Lars A. Akslen,Linda Sleire,Per Øyvind Enger,Rolf K. Reed,Anne M. Øyan,Linda Stuhr	17
12	Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma 2011 ·PLoS ONE ·Jian Wang,Agnete Svendsen,Justyna Kmiecik,Heike Immervoll,Kai Ove Skaftnesmo,Jesús Planagumà,Rolf K. Reed,Rolf Bjerkvig,Hrvoje Miletić,Per Øyvind Enger,Cecilie Brekke Rygh,Martha Chekenya	87
13	Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence‐activated cell sorting 2010 ·Immunology ·Aurélie Poli,Nicolaas H. C. Brons,Wim Ammerlaan,Tatiana Michel,François Hentges,Martha Chekenya,Jacques Zimmer	9
14	Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation 2009 ·Cancer Letters ·Joost J.C. Verhoeff,Lukas J.A. Stalpers,Cornelis J.F. Van Noorden,Dirk Troost,Marja Ramkema,Chris van Bree,Ji‐Ying Song,Mila Donker,Martha Chekenya,W. Peter Vandertop,Dick J. Richel,Wouter R. van Furth	5
15	NG2, a novel proapoptotic receptor, opposes integrin α4 to mediate anoikis through PKCα-dependent suppression of FAK phosphorylation 2008 ·Cell Death and Differentiation ·Nam Eok Joo,T. Watanabe,(unknown),Martha Chekenya,William B. Stallcup,Yvonne L. Kapila	34
16	The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling 2008 ·Oncogene ·Martha Chekenya,Camilla Krakstad,Agnete Svendsen,Inger Anne Netland,Vidar Staalesen,Berit B. Tysnes,Frode Selheim,Jian Wang,Per Øystein Sakariassen,Tone Sandal,Per Eystein Lønning,Torgeir Flatmark,Per Øyvind Enger,Rolf Bjerkvig,Mouldy Sioud,William B. Stallcup	127
17	Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies 2007 ·Neoplasia ·Per Øystein Sakariassen,Heike Immervoll,Martha Chekenya	123
18	NG2/HMP Proteoglycan as a Cancer Therapeutic Target 2006 ·Humana Press eBooks ·Martha Chekenya,Heike Immervoll	7
19	The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours 2002 ·Neuropathology and Applied Neurobiology ·Martha Chekenya,Per Øyvind Enger,Frits Thorsen,Berit B. Tysnes,Safa Al‐Sarraj,Tracy‐Ann Read,Tomasz Furmanek,Rupavathana Mahesparan,Joel M. Levine,Arthur M. Butt,G. J. Pilkington,Rolf Bjerkvig	61
20	NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumours 2002 ·Journal of Neurocytology ·Martha Chekenya,G. J. Pilkington	51

About Martha Chekenya

Martha Chekenya is a scholar working on Genetics, Immunology and Cancer Research, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Genetics (578 citations), Immunology (739 citations) and Oncology (763 citations). Martha Chekenya has collaborated with scholars based in Norway, Luxembourg and United States. Frequent co-authors include Camilla Krakstad, Per Øyvind Enger, Jacques Zimmer, Justyna Kmiecik, Andrea Gras Navarro, Aurélie Poli, Per Øystein Sakariassen, Heike Immervoll, Andreas T. Björklund and Andreas Waha. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact